Mira Pharmaceuticals, Inc. MIRA US Equity
Mira Pharmaceuticals, Inc. (Nasdaq: MIRA), an SEC filer in Pharmaceutical Preparations, closed at $0.77, +2.7%, on 2026-08-27, with a market cap of $32M and a return on equity of -165.9%. Institutional ownership, earnings history, filed financials and clinical trials are on the tabs below.
Documents
| Period end | Filed | Form | Read here | EDGAR |
|---|---|---|---|---|
| 2025-12-31 | 2026-03-31 | 10-K | read · risk factors · MD&A | index · original · 0001493152-26-014001 |
| 2024-12-31 | 2025-03-28 | 10-K | read · risk factors · MD&A | index · original · 0001641172-25-001183 |
| 2023-12-31 | 2024-04-01 | 10-K | read · risk factors · MD&A | index · original · 0001493152-24-012141 |
▾Risk registerwhich risk-factor headings appeared in which year
Descriptive and within-name: this is what changed in the wording of one firm's own filings.
A register needs two comparable years of risk-factor headings; 0 of the 3 cached 10-Ks for MIRA produced any.
2023-12-31: Item 1A could not be bounded safely in this filing, so nothing is read from it. The item extractor suppresses a section whose boundaries are doubtful rather than report a mis-bounded one — a wrong section is a wrong reading.
2024-12-31: Item 1A could not be bounded safely in this filing, so nothing is read from it. The item extractor suppresses a section whose boundaries are doubtful rather than report a mis-bounded one — a wrong section is a wrong reading.
2025-12-31: Item 1A could not be bounded safely in this filing, so nothing is read from it. The item extractor suppresses a section whose boundaries are doubtful rather than report a mis-bounded one — a wrong section is a wrong reading.
The filer's own 10-K text · 3 filings read
Rows are the filing's own headings, verbatim — nothing is summarized or generated.
A blank cell means the filer did not print that heading that year — not that the risk ended.
Gates: 5+ captions · 50% of Item 1A · match at Jaccard 0.6.
▾Filing languagedocument length, negation and hedging — chart it against price on GRAPH
3 filings measured
Descriptive and within-name: this is what changed in the wording of one firm's own filings.
| Filed | Period end | Document words | Item 1A words | Negation / 10k | Hedging / 10k | Filing |
|---|---|---|---|---|---|---|
| 2024-04-01 | 2023-12-31 | 58,643 | — | 66.33 | 181.44 | read · EDGAR ↗ |
| 2025-03-28 | 2024-12-31 | 56,727 | — | 75.1 | 182.81 | read · EDGAR ↗ |
| 2026-03-31 | 2025-12-31 | 53,442 | — | 81.96 | 189.36 | read · EDGAR ↗ |
plot against the price on GRAPH: Document length · Item 1A length · Negation per 10k words · Hedging per 10k words
The filer's own 10-K text · 3 filings measured
House wordlists, not a licensed dictionary and not tuned against returns.
9 negation words · 40 hedging words — hover to read both lists.
Each point sits at its filing date and is held flat until the next filing.